Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
Date:2/22/2008

was primarily attributable to a $7,839,000 increase in research and development expenses related to the Company's Sulonex pivotal Phase 3 and Phase 4 clinical program, a $6,702,000 increase in expenses related to KRX-0401 (perifosine), a $3,294,000 increase in expenses related to Zerenex (ferric citrate) and a $1,580,000 increase in expenses related to the Company's other clinical compounds. The increase in net loss was also due to a $1,838,000 decrease in interest and other income. The increase in net loss was partially offset by a $4,252,000 decrease in non- cash compensation expense related to stock option and restricted stock grants.

Commenting on the year and the quarter, Michael S. Weiss, Keryx's Chairman and Chief Executive Officer, said, "This was an important year for the Company as we made substantial progress toward the potential commercialization of Sulonex, including: completion of the active treatment portion of the SUN- MICRO Phase 3 trial with the subsequent completion of the trial in February 2008; enrollment of over 50% of the patients required for completion of the SUN-MACRO Phase 4 trial; completion of four Independent Data Safety Monitoring Committee (DSMC) meetings surrounding the Phase 3 and Phase 4 trials culminating in the fourth quarter DSMC final review of the safety and efficacy data related to the Sulonex Phase 3 trial, at which time the DSMC again found no cogent reason to recommend that we alter or terminate the study; and the completion of our first commercial-scale manufacturing facility with final validation anticipated in 2008." Mr. Weiss, continued, "With the Phase 3 trial now complete, we anxiously await the final results from the study, and continue to target making an announcement of the top line data before the end of next month. In preparation for the potential commercial launch of Sulonex, we continue to build our internal expertise, including key hires in commercial, medical affairs, quality operations, legal and ac
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
2. Keryx Biopharmaceuticals Announces Additions to Management Team
3. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
4. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
7. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
8. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
9. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
10. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
11. Genta Announces Senior Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... http://www.researchandmarkets.com/research/cmbgcv/north_american ) has announced the addition ... Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET ... (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & ... report to their offering. ...
(Date:6/18/2013)... New user friendly innovations in table ... the dangers of misuse and ineffective sterilization. Older ... gauges, hot surfaces and complex door latches. Whether ... autoclave, Revolutionary Science explains some important points to remember. ... designs will recycle dirty water. This method can ...
(Date:6/18/2013)... 2013 ActiGraph, a leading provider of ... global research community, announced today that Dr. Victor KR ... is the Scientific Director of the Physical Fitness Research ... of Medicine at Gama Filho University and the Chairman ... State Secretariat of Health of São Paulo State, Brazil. ...
(Date:6/18/2013)... 18, 2013 Kitware , a ... a new Fast-Track award from the U.S. Department of ... (IDAE) for the nuclear power industry. , Construction of ... than 30 years, but the United States’ nuclear power ... in power plant utilization through improved refueling, maintenance, and ...
Breaking Biology Technology:North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board 2Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2
... - The nation's fifth largest school district is being ... Johnson Controls, Inc. , to deter sexual predators from ... its attempts to develop hybrid car batteries and energy-efficient ... next month, utilizing digital identification checkpoints in 250 ...
... M ilwaukee, Wis. - Teresa Esser ... Wisconsin and, as the new director of the Milwaukee-based ... to see more of that opportunity realized. , ,While ... of capital in Wisconsin, particularly in the tech sector, ...
... a modest renewable fuel standard contained in the Energy ... and Congressman Ron Kind have called for a ... appearance at the Farmers Cooperative Shipping and Supply Association, Doyle ... the RFS, and they touted the economic and energy independence ...
Cached Biology Technology:Florida schools employ Johnson Controls technology to stop sex predators 2New Silicon Pastures director envisions more home cooking for Wisconsin angels 2New Silicon Pastures director envisions more home cooking for Wisconsin angels 3New Silicon Pastures director envisions more home cooking for Wisconsin angels 4New Silicon Pastures director envisions more home cooking for Wisconsin angels 5New Silicon Pastures director envisions more home cooking for Wisconsin angels 6Doyle, Kind call for higher renewable fuel standard 2Doyle, Kind call for higher renewable fuel standard 3
(Date:6/17/2013)... Kansas State University research associate has received a prestigious ... to prevent the spread of malaria. , Bart Bryant, ... of Health,s National Research Service Award Individual Postdoctoral Fellowship, ... seventh Kansas State University researcher to receive the award ... hold such an award. , Bryant, a university doctoral ...
(Date:6/17/2013)... method of mining shale gas, is widespread across Pennsylvania, ... New research in the Annals of the New ... to biodiversity including pollution from toxic chemicals, the building ... , "Shale gas has engendered a great deal of ... but effects on biological diversity and resources have scarcely ...
(Date:6/16/2013)... A mechanism that cells use to group together and move ... been described for the first time by scientists at UCL. ... new study focuses on the process that occurs when cancer ... the body during metastasis. Scientists know that cancer cells recruit ... how this process takes place and how it could be ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2'Chase and run' cell movement mechanism explains process of metastasis 2
... moderate to severe chest pains (angina) who have not ... gene therapy approach being used by cardiologists at Rush ... the heart. , The phase II clinical research study ... of a solution containing a DNA plasmid that is ...
... Implanted devices intended to optimize the cardiac function of ... which patients might be at higher risk of dying ... University Medical Center. , Besides maintaining optimal electrical stimulation ... defibrillation) devices are giving cardiologists a new view of ...
... has used gene therapy in two separate studies to ... and rats with a drug-induced form of Parkinson's disease. ... Brain and The Journal of Neuroscience, essentially describes one ... another strategy to treat the devastating side effects that ...
Cached Biology News:Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments 2Implanted Devices Detect High-Risk Heart Failure Patients 2Implanted Devices Detect High-Risk Heart Failure Patients 3Gene therapy for Parkinson's disease moves forward in animals 2Gene therapy for Parkinson's disease moves forward in animals 3Gene therapy for Parkinson's disease moves forward in animals 4
... 'The DNAscope V is a ... microarray scanning and image processing that deliver ... V is a high quality microarray scanner ... imaging technology for optimal background rejection and ...
... Phospho-Specific(Thr 222 ) ... 10 mM sodium HEPES, 100 ... 7.5. Recognizes the ~47 kDa ... (MAPKAPK-2) protein phosphorylated at Thr ...
Anti-Src-Like Adaptor Protein-2 AVOID FREEZE/THAW CYCLES. Recognizes the ~25 and ~28 kDa forms SLAP-2....
Goat polyclonal to Centaurin alpha 2**...
Biology Products: